F020 Wounds, Wounds and More Wounds!
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
This session will cover hot topics in wound healing. Diagnosis and treatment of chronic and acute wounds in the setting of complex medical dermatology diseases as well as pediatrics will be discussed. Emphasis will be put on clinically relevant data that the learner can consider for their daily practice.
LEARNING OBJECTIVES
Appraise new wound healing innovations on the market that are relevant to the day-to-day practice of a dermatologist.
Discuss emerging evidence in wound healing aspects of care for pediatrics, inflammatory skin disease, immunobullous disease, and connective tissue disease.
SCHEDULE
9:00 PM
Wounds from the end of the textbook - case-based panel
Hadar Lev-Tov, MD, FAAD, Andrea Maderal, MD, FAAD, Robert Micheletti, MD, FAAD, Brittney Schultz, MD, FAAD
10:00 PM
Pediatric wounds
Lawrence F Eichenfield, MD, FAAD
10:30 PM
What's new in wound healing?
Hadar Lev-Tov, MD, FAAD
SPEAKERS
Lawrence F Eichenfield, MD, FAAD
Hadar Lev-Tov, MD, FAAD
Andrea Maderal, MD, FAAD
Robert Micheletti, MD, FAAD
Brittney Schultz, MD, FAAD
HANDOUTS
SPEAKER DISCLOSURES
Lawrence F Eichenfield, MD, FAAD
AbbVie – Consultant(Honoraria); Abbvie – Investigator(Grants/Research Funding); Almirall – Consultant(Honoraria); Amgen – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Amryt Pharma – Consultant(Honoraria); Arcutis Biotherapeutics – Investigator(Grants/Research Funding); ASLAN Pharmaceuticals – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Bristol-Myers Squibb – Consultant(Honoraria); Castle Biosciences, Inc – Investigator(Grants/Research Funding); Dermata Therapeutics – Consultant (1099 relationship)(Stock); Dermavant Sciences, Inc. – Consultant(Honoraria); Eli Lilly – Consultant(Honoraria), Investigator(Grants/Research Funding); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Forte Biosciences – Board of Directors(Fees), Board of Directors(Stock Options); Galderma Laboratories, L.P. – Consultant(Honoraria), Investigator(Fees); Incyte Corporation – Consultant(Honoraria); Janssen Pharmaceuticals, Inc – Consultant (1099 relationship)(Honoraria); Krystal Biotech, Inc – Consultant(Honoraria); LEO Pharma, US – Consultant(Honoraria), Investigator(Fees); Lilly ICOS LLC – Consultant(Honoraria); Nobelpharma – Consultant(Honoraria); Ortho Dermatologics – Investigator(Grants/Research Funding); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Sanofi/Regeneron – Consultant(Honoraria), Investigator(Fees); TopMD – Consultant(Stock Options); TrialSpark, Inc. – Consultant(Honoraria); UCB – Consultant(Honoraria); Verrica Pharmaceuticals Inc – Board of Directors(Fees), Board of Directors(Stock Options); Wiley-Blackwell – Other(Honoraria);
Hadar Lev-Tov, MD, FAAD
AbbVie – Consultant(Fees); BSN Medical – Investigator(Grants/Research Funding), Speaker(Honoraria); Cosmo Pharmaceuticals Inc. – Consultant (1099 relationship)(Fees); Hidradenitis Suppurativa Foundation – Board of Directors(No Compensation Received); HidraMed Solutions – Advisory Board(Fees); Incyte Corporation – Investigator(No Compensation Received); Insmed Incorporated – Consultant (1099 relationship)(Fees); LearnHealth/LearnSkin – Founder(Stock); Learnskin – Founder(Stock Options); Medline Industries, Inc. – Investigator(Grants/Research Funding), Speaker(Honoraria); Molynlycke – Consultant(Fees), Speaker(Honoraria); Next Science – Consultant(Fees); Novartis – Consultant(Fees); Pfizer Inc. – Advisory Board(Honoraria), Consultant(Fees), Investigator(No Compensation Received); SAWC – Speaker(Honoraria); TissueTech – Investigator(No Compensation Received); UCB – Investigator(No Compensation Received); Vomaris Innovations Inc – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding);
Andrea Maderal, MD, FAAD
argenx – Consultant (1099 relationship)(Fees); aTyr Pharma – Investigator(Other Financial Benefit); Biogen – Investigator(Other Financial Benefit); Bristol Myers Squibb – Investigator(Other Financial Benefit);
Robert Micheletti, MD, FAAD
Acelyrin – Investigator(Grants/Research Funding); Boehringer Ingelheim – Investigator(Grants/Research Funding); Cabaletta Bio – Investigator(Grants/Research Funding); InflaRx – Investigator(Grants/Research Funding); Vertex Pharmaceuticals, Inc. – Consultant(Fees);
Brittney Schultz, MD, FAAD
arGEN-X – Advisory Board(Honoraria); AstraZeneca – Investigator(No Compensation Received); Elorac, Inc. – Investigator(No Compensation Received);